ArticleRevista da Associacao Medica Brasileira (1992)2026
Association of Vascular Endothelial Growth Factor A-2549 I/D polymorphism with polycystic ovary syndrome susceptibility in Turkish women.
Article in Revista da Associacao Medica Brasileira (1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this case-control study was to evaluate whether the Vascular Endothelial Growth Factor A promoter rs35569394 (-2549 insertion/deletion) polymorphism is associated with polycystic ovary syndrome risk and related clinical-metabolic features.
methodsThe study included 104 women with polycystic ovary syndrome diagnosed according to Rotterdam criteria and 128 controls. Clinical, hormonal, and metabolic variables were recorded, homeostatic model assessment of insulin resistance was calculated, and Vascular Endothelial Growth Factor A-2549 insertion/deletion genotypes were determined by direct polymerase chain reaction. Hardy-Weinberg equilibrium was assessed in controls. Benjamini-Hochberg false-discovery-rate-adjusted p-values were calculated for the 11 clinical comparisons, while prespecified Bonferroni-adjusted p-values were retained for genotype and family-history contrasts.
resultsBody mass index, prolactin, homeostatic model assessment of insulin resistance, insulin, follicle stimulating hormone, luteinizing harmone, and total testosterone were higher in the polycystic ovary syndrome group. Overall genotype distribution differed between groups (Cramer's V=0.20; chi-square=8.87, p=0.012). The detection/deletion genotype was more frequent in polycystic ovary syndrome patients than controls (30.77% vs. 15.63%; Cohen's h=0.36; raw p=0.007; Bonferroni-adjusted p=0.028; OR 2.40, 95%CI 1.28-4.51). The family-history detection/deletion comparison did not remain significant after adjustment (raw p=0.018; adjusted p=0.072). Hardy-Weinberg equilibrium analysis in controls yielded an exact p-value of 0.050 and a Pearson p-value of 0.037.
conclusionIn this Turkish case-control sample, the Vascular Endothelial Growth Factor A-2549 insertion/deletion detection/deletion genotype was more frequent among women with polycystic ovary syndrome than among controls. This observed association does not establish causality, a functional effect, phenotype-specific relevance, or clinical utility. Deviation from Hardy-Weinberg equilibrium in controls, residual confounding from incomplete matching, limited power, and lack of functional validation make the finding preliminary. Independent validation in larger, well-matched cohorts with prespecified genotyping quality control, phenotype stratification, and functional studies is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.